---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-22-000014"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2022-02-09T23:59:59+00:00"
generated_at: "2026-06-27T09:49:00.295523+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics CSO Jerry Lanchbury retires; severance $782k plus equity acceleration

## Summary
- Jerry Lanchbury retired as Chief Scientific Officer effective Jan 14, 2022, will consult through Mar 31, 2022.
- Lump sum severance of $782,276.93; weekly consulting fee of $500; additional $45,401.67 possible at end.
- Unvested equity awards scheduled to vest within two years of transition are accelerated, with performance-based awards subject to conditions.
- Non-compete and non-solicitation covenants apply for 12 months after the consulting period.
- Eligible for 2021 annual bonus as determined by Compensation Committee.

## SEC filing metadata
- accession: 0000899923-22-000014
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2022-02-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992322000014/0000899923-22-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992322000014/mygn-20220207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-22-000014
- JSON: https://secwatch.observer/filing/0000899923-22-000014.json
- Plain text: https://secwatch.observer/filing/0000899923-22-000014.txt

## Key facts
- Executive change
  Jerry Lanchbury retired as Chief Scientific Officer at MYRIAD GENETICS INC.
  - Action: retired
  - Role: Chief Scientific Officer
  source text: As previously disclosed, Dr. Lanchbury announced his retirement as Chief Scientific Officer of the Company, effective January 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992322000014/0000899923-22-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.